Kapitalo Investimentos’s Nu Skin NUS Stock Holding History

Kapitalo Investimentos’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-41,372	Closed	-$331K	–	110
2025 Q2	$331K	Buy	+41,372	New	+$290K	0.07%	52

Other funds holding NUS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kapitalo Investimentos's NUS Position: Q3 2025 in Review

Kapitalo Investimentos sold out of Nu Skin (NUS) in Q3 2025, closing a stake of 41,372 shares — an estimated $331K sold.

Kapitalo Investimentos first reported a position in NUS in Q2 2025 and held it in 1 quarter. The position peaked at $331K in Q2 2025. 194 funds tracked by Wall St. Rank hold NUS as of Q3 2025.

Kapitalo Investimentos reported no remaining Nu Skin position as of Q3 2025 after selling out during the quarter.
Kapitalo Investimentos sold 41,372 Nu Skin shares in Q3 2025, an estimated $331K.
Kapitalo Investimentos first reported a position in Nu Skin in Q2 2025 and held it in 1 quarter.
Kapitalo Investimentos's Nu Skin position peaked at $331K in Q2 2025.
194 funds tracked by Wall St. Rank held Nu Skin as of Q3 2025.

Based on Kapitalo Investimentos's 13F filing for Q3 2025, filed 3 Nov 2025.